Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling

Jessica Pamment1, Eleanor Ramsay, Michael Kelleher

  • 1Cancer Research UK Laboratories, University of Dundee Medical School, Dundee DD1 9SY, UK.

Oncogene
|November 7, 2002
PubMed

Insights

Genotoxic stress activates the ATM-signalling pathway to induce Interferon Regulatory Factor-1 (IRF-1) and p53, crucial for DNA damage response. This contrasts with the JAK/STAT pathway used during viral infections.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Cancer Research

Background:

  • The precise mechanisms by which genotoxic stress triggers Interferon Regulatory Factor-1 (IRF-1) induction remain unclear.
  • Understanding upstream signaling components is vital for elucidating the DNA damage response pathway involving IRF-1.

Purpose of the Study:

  • To investigate the role of ATM kinase in the induction of IRF-1 during DNA damage.
  • To explore the coordinated regulation of IRF-1 and p53 in response to genotoxic stress.
  • To differentiate the signaling pathways controlling IRF-1 in response to DNA damage versus viral mimetics.

Main Methods:

  • Utilized ionizing radiation (IR) and etoposide to induce genotoxic stress in ATM-deficient and ATM-positive cells.
  • Assessed IRF-1 mRNA and protein levels.
  • Investigated the effect of ATM re-expression and PI-3 kinase inhibition (wortmannin) on IRF-1 induction.

Main Results:

  • IRF-1 and p53 are coordinately upregulated in an ATM-dependent manner following DNA damage.
  • ATM-deficient cells exhibit a significant defect in IRF-1 induction by genotoxic stress, but not viral mimetics.
  • ATM kinase activity is essential for DNA damage-induced IRF-1 expression and stability.

Conclusions:

  • The ATM kinase plays a critical role in orchestrating the coordinated induction and transcriptional cooperation of IRF-1 and p53 to regulate p21 expression.
  • IRF-1 is regulated by distinct signaling pathways: JAK/STAT for viral infections and ATM for DNA damage.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...